Please assess the completion status of the following clinical trial:

Trial Title: Innovation for Standard Identification of Insertional HPV Mutations and of Target Therapeutic Genes in Cervical Cancer: Towards Development of Personalized Biomarkers in Clinical Oncology

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Patient with cervical cancer, at any stage, before any anti-tumoral treatment.~2. Age ≥ 18 years.~3. Patient information and signature of the informed consent or her/his legal representative.~4. Patient having given her/his agreement for a second biopsy at diagnosis if the first one was performed outside of the center and was not cryopreserved.~Exclusion Criteria:~1. Person deprived of liberty or under supervision.~2. Inability to attend scheduled follow-up visits for any psychological, sociological or geographical reasons.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Tumor biopsies and blood sampling (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).